Georgia
Phase 3 cancer trials in Georgia
112 Phase 3 cancer studies are recruiting participants at sites in 32 cities across Georgia as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Georgia city with a recruiting study
By research area: Lung Cancer (39), Breast Cancer (27), Lymphoma (16), Prostate Cancer (15), Pancreatic Cancer (8), Melanoma (7).
Atlanta (76), Savannah (23), Newnan (17), Marietta (15), Athens (14), Decatur (14), Johns Creek (12), Augusta (10), Duluth (7), Lawrenceville (7), Macon (7), Albany (4), Gainesville (4), Columbus (3), Dalton (3), Thomasville (3), Valdosta (3), Fayetteville (2), Ringgold (2), Stockbridge (2), Alpharetta (1), Austell (1), Braselton (1), Canton (1), Cumming (1), Hinesville (1), Pembroke (1), Rome (1), Snellville (1), Statesboro (1), Tifton (1), Warner Robins (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Georgia
Basic details from each study's public record (the 12 most recently updated of 112). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Athens
- Registry record
- NCT06841354 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Newnan
- Registry record
- NCT06966700 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Georgia on ClinicalTrials.gov.
Lung cancer: recently updated in Georgia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Atlanta · Decatur · Johns Creek
- Registry record
- NCT06498635 · updated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Recruiting in
- Atlanta · Warner Robins
- Registry record
- NCT06767514 · updated
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Recruiting in
- Atlanta
- Registry record
- NCT06899126 · updated
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Atlanta · Marietta
- Registry record
- NCT07195695 · updated
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Mirati Therapeutics Inc.
- Recruiting in
- Marietta
- Registry record
- NCT06875310 · updated
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Texas Southwestern Medical Center
- Recruiting in
- Savannah
- Registry record
- NCT02468024 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Georgia on ClinicalTrials.gov.
Prostate cancer: recently updated in Georgia
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- BioNTech SE
- Recruiting in
- Atlanta
- Registry record
- NCT07365995 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Georgia on ClinicalTrials.gov.
Lymphoma: recently updated in Georgia
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Atlanta · Augusta
- Registry record
- NCT06337318 · updated
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Nuvation Bio Inc.
- Recruiting in
- Atlanta
- Registry record
- NCT05303519 · updated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Recruiting in
- Atlanta
- Registry record
- NCT06724237 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Georgia on ClinicalTrials.gov.
Ask about studies in Georgia
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry.
Phase 3 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections